Plain-English translation of NCT06068335 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Asthma research guide →Researchers are trying to understand how the immune system responds differently in people with allergic asthma compared to people with allergies alone or people without either condition. By studying blood samples from volunteers, they hope to identify a biological 'signature' — specific markers and patterns in immune cells — that could help doctors better diagnose and understand allergic asthma in the future.
Currently, doctors diagnose asthma and allergies based on symptoms and tests, but they don't fully understand the underlying immune differences between people with these conditions. This research aims to find biological markers that could improve diagnosis and potentially lead to better treatments.
You likely qualify if…
You likely don't qualify if…
Your participation would involve donating a blood sample, which the research team will use to study how your immune cells respond to different allergens in the laboratory. The study is observational, meaning researchers are collecting and analyzing samples rather than giving you a treatment to try. Beyond the blood draw, participation is straightforward and doesn't involve ongoing visits or medications.
AI-generated summary from trial data · Jun 5, 2026 · Not medical advice
United States
Enrollment target
~100 participants
Started
October 2021
Primary completion
June 2025
This trial's estimated completion date has passed — the record may not be fully up to date.
Age range
18 Years and older
Last updated on clinicaltrials.gov in December 2024.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Amoy Fraser, PhD, CCRP, PMP
University of Central Florida
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.